| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |